由于需求低,加拿大公共卫生局不订购Novavax的COVID-19疫苗。 Public Health Agency of Canada does not order Novavax's COVID-19 vaccine due to low demand.

加拿大公共卫生局将不订购Novavax的COVID-19疫苗Nuvaxovid,因为这一呼吸季节的需求量较低。 The Public Health Agency of Canada will not order Novavax's COVID-19 vaccine, Nuvaxovid, this respiratory season due to low demand. 制造商要求的最低订单超过去年的摄入量,当时仅施用125 000剂中的5 529剂。 The manufacturer requires a minimum order that surpasses last year's uptake, where only 5,529 of 125,000 doses were administered. 这项决定旨在尽量减少疫苗浪费。 This decision aims to minimize vaccine wastage. Novavax 和辉瑞的疫苗都经过重新配制，以针对 Omicron KP.2 亚变体。 Both Novavax's and Pfizer’s vaccines have been reformulated to target the Omicron KP.2 subvariant.